Germ-line mutation of NKX3.1 cosegregates with hereditary prostate cancer and alters the homeodomain structure and function

• Published in: Cancer research (Chicago, Ill.) Ill.), 2006, Vol.66 (1), p.69-77
• Main Authors: ZHENG, S. Lilly, JU, Jeong-Ho, WALSH, Patrick C, FERRETTI, James, GRUSCHUS, James, ISAACS, William B, GELMANN, Edward P, JIANFENG XU, CHANG, Bao-Li, ORTNER, Elizabeth, JIELIN SUN, ISAACS, Sarah D, JISHANG SUN, WILEY, Kathy E, WENNUAN LIU, ZEMEDKUN, Micheas
• Format: Article
• Language: English
• Subjects: Amino Acid Sequence; Biological and medical sciences; Chromosome Segregation; Chromosomes, Human, Pair 8 - genetics; DNA, Neoplasm - genetics; DNA, Neoplasm - metabolism; DNA-Binding Proteins - genetics; DNA-Binding Proteins - metabolism; Genetic Linkage; Genetic Predisposition to Disease; Germ-Line Mutation; Gynecology. Andrology. Obstetrics; Homeodomain Proteins - genetics; Homeodomain Proteins - metabolism; Humans; Male; Male genital diseases; Medical sciences; Middle Aged; Models, Molecular; Molecular Sequence Data; Nephrology. Urinary tract diseases; Nuclear Magnetic Resonance, Biomolecular; Prostatic Neoplasms - genetics; Prostatic Neoplasms - metabolism; Protein Structure, Tertiary; RNA, Messenger - genetics; Structure-Activity Relationship; Transcription Factors - genetics; Transcription Factors - metabolism; Tumors; Tumors of the urinary system; Urinary tract. Prostate gland
• ISSN: 0008-5472; 1538-7445
• DOI: 10.1158/0008-5472.CAN-05-1550

NKX3.1, a gene mapped to 8p21, is a member of the NK class of homeodomain proteins and is expressed primarily in the prostate. NKX3.1 exerts a growth-suppressive and differentiating effect on prostate epithelial cells. Because of its known functions and its location within a chromosomal region where evidence for prostate cancer linkage and somatic loss of heterozygosity is found, we hypothesize that sequence variants in the NKX3.1 gene increase prostate cancer risk. To address this, we first resequenced the NKX3.1 gene in 159 probands of hereditary prostate cancer families recruited at Johns Hopkins Hospital; each family has at least three first-degree relatives affected with prostate cancer. Twenty-one germ-line variants were identified in this analysis, including one previously described common nonsynonymous change (R52C), two novel rare nonsynonymous changes (A17T and T164A), and a novel common 18-bp deletion in the promoter. Overall, the germ-line variants were significantly linked to prostate cancer, with a peak heterogeneity logarithm of odds of 2.04 (P = 0.002) at the NKX3.1 gene. The rare nonsynonymous change, T164A, located in the homeobox domain of the gene, segregated with prostate cancer in a family with three affected brothers and one unaffected brother. Importantly, nuclear magnetic resonance solution structure analysis and circular dichroism studies showed this specific mutation to affect the stability of the homeodomain of the NKX3.1 protein and decreased binding to its cognate DNA recognition sequence. These results suggest that germ-line sequence variants in NKX3.1 may play a role in susceptibility to hereditary prostate cancer and underscore a role for NKX3.1 as a prostate cancer gatekeeper.